iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.430
0.00 (0.00%)
At close: May 1, 2024, 4:00 PM
1.470
+0.040 (2.80%)
After-hours: May 1, 2024, 7:59 PM EDT

iCAD, Inc. Revenue

In the year 2023, iCAD, Inc. had annual revenue of $17.32M, a decrease of -12.54%. Revenue in the quarter ending December 31, 2023 was $4.74M with 2.27% year-over-year growth.

Revenue (ttm)
$17.32M
Revenue Growth
-12.54%
P/S Ratio
2.19
Revenue / Employee
$258,478
Employees
67
Market Cap
37.95M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.32M-2.48M-12.54%
Dec 31, 202219.80M-13.84M-41.13%
Dec 31, 202133.64M3.94M13.27%
Dec 31, 202029.70M-1.64M-5.24%
Dec 31, 201931.34M5.72M22.32%
Dec 31, 201825.62M-2.48M-8.83%
Dec 31, 201728.10M1.76M6.70%
Dec 31, 201626.34M-15.22M-36.62%
Dec 31, 201541.55M-2.37M-5.40%
Dec 31, 201443.92M10.86M32.83%
Dec 31, 201333.07M4.79M16.95%
Dec 31, 201228.28M-377.00K-1.32%
Dec 31, 201128.65M4.08M16.59%
Dec 31, 201024.58M-3.53M-12.57%
Dec 31, 200928.11M-9.38M-25.03%
Dec 31, 200837.49M10.88M40.88%
Dec 31, 200726.61M6.89M34.94%
Dec 31, 200619.72M-48.46K-0.25%
Dec 31, 200519.77M-3.54M-15.18%
Dec 31, 200423.31M16.79M257.47%
Dec 31, 20036.52M1.52M30.40%
Dec 31, 20025.00M164.89K3.41%
Dec 31, 20014.84M-2.96M-37.96%
Dec 31, 20007.79M1.13M16.96%
Dec 31, 19996.66M1.34M25.16%
Dec 31, 19985.32M-2.55M-32.40%
Dec 31, 19977.87M-3.39M-30.08%
Dec 31, 199611.26M-9.34M-45.33%
Dec 31, 199520.60M-3.77M-15.46%
Dec 31, 199424.37M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owlet 54.01M
ImmuCell 17.47M
ReWalk Robotics 13.85M
Dyadic International 2.90M
SAB Biotherapeutics 2.24M
Revenue Rankings